|Podcasts|February 11, 2022
Price Transparency Regulations are Accelerating Market Disruption. Are You Prepared?
Author(s)Deloitte LLP
As pricing transparency regulations and COVID-19 accelerate market disruption and changes in consumer behavior demand new engagement models, how can your organization prepare for the powerful shift toward more consumer-centric pricing transparency?
Related Content
Trending on PharmExec
1
Modern Policy Concerns Stemming from 340B
2
Funding Roundup: Silence Therapeutics, AbCellera Announce IPO Pricing, Beyang, Remepy Close Series A Financing
3
Pharmaceutical Executive Daily: Mereo BioPharma Enters Option and License Agreement with Sentynl Therapeutics
4
2026 Emerging Pharma Leaders
5